Originally published In Press as doi:10.1074/jbc.M110023200 on December 13, 2001
J. Biol. Chem., Vol. 277, Issue 9, 7598-7609, March 1, 2002
Characterization of Two Novel Nuclear BTB/POZ Domain Zinc Finger
Isoforms
ASSOCIATION WITH DIFFERENTIATION OF HIPPOCAMPAL NEURONS,
CEREBELLAR GRANULE CELLS, AND MACROGLIA*
Cathy
Mitchelmore,
Karen M.
Kjærulff,
Hans C.
Pedersen,
Jakob V.
Nielsen,
Thomas E.
Rasmussen,
Mads F.
Fisker,
Bente
Finsen
,
Karen M.
Pedersen, and
Niels A.
Jensen§
From the Laboratory of Mammalian Molecular Genetics, The Panum
Institute 6.5, University of Copenhagen, Blegdamsvej 3,
DK-2200 Copenhagen N and the
Department of Anatomy and
Neurobiology, University of Odense, Winsløwparken 21,
DK-5000 Odense C, Denmark
Received for publication, October 17, 2001, and in revised form, December 10, 2001
 |
ABSTRACT |
BTB/POZ (broad complex
tramtrack bric-a-brac/poxvirus and
zinc finger) zinc finger factors are a class of nuclear
DNA-binding proteins involved in development, chromatin remodeling, and
cancer. However, BTB/POZ domain zinc finger factors linked to
development of the mammalian cerebral cortex, cerebellum, and macroglia
have not been described previously. We report here the isolation and characterization of two novel nuclear BTB/POZ domain zinc finger isoforms, designated HOFL and HOFS, that
are specifically expressed in early hippocampal neurons, cerebellar
granule cells, and gliogenic progenitors as well as in differentiated
glia. During embryonic development of the murine cerebral cortex, HOF
expression is restricted to the hippocampal subdivision. Expression
coincides with early differentiation of presumptive CA1 and CA3
pyramidal neurons and dentate gyrus granule cells, with a sharp decline
in expression at the CA1/subicular border. By using bromodeoxyuridine
labeling and immunohistochemistry, we show that HOF expression
coincides with immature non-dividing cells and is down-regulated in
differentiated cells, suggesting a role for HOF in hippocampal
neurogenesis. Consistent with the postulated role of the POZ domain as
a site for protein-protein interactions, both HOF isoforms are able to
dimerize. The HOF zinc fingers bind specifically to the binding site
for the related promyelocytic leukemia zinc finger protein as well as
to a newly identified DNA sequence.
 |
INTRODUCTION |
The hippocampus is located at the medial-temporal edge of
the neocortex and harbors neural circuitry that is crucial for
cognitive functions such as learning and memory (1). Anatomically, it can be distinguished as two distinct subregions, the dentate gyrus (DG)1 and the hippocampus
proper (or Ammon's horn) with its three subfields CA1, CA2, and CA3
(2). Lateral to the CA1 subfield lies the subiculum, pre-, and
parasubiculum, which are regarded as transitional neocortical areas
located between the hippocampus proper and the entorhinal cortex (3).
During early development of the cerebral cortex, the hippocampal
neuroepithelium is organized into distinct germinative zones that
specify the development of CA pyramidal neurons, DG granule neurons,
and fimbrial glial cells (4, 5). Newly born Ammon's horn pyramidal
precursor neurons exhibit a delay in migration to the hippocampal plate
(HP) in which they reside temporally in an inferior band referred to as
the intermediate zone (6). After sojourn in the intermediate zone,
presumptive pyramidal precursors settle in the HP plate in an
"inside-out" sequence where first born neurons constitute deep
layers and later generated neurons settle above in more superficial
(external) locations. In contrast to morphogenesis of the neocortex
where cortical plate neurons segregate radially into layers of
functionally distinct neurons, pyramidal neurons of the Ammon's horn
remain settled in a single homogenous layer.
Granule cell neurogenesis in the hippocampus is complex and
involves at least two germinative zones. An early wave of migrating granule cell precursors originate in a distinct subdomain of the hippocampal neuroepithelium, designated the dentate notch, which consists of a mixture of post-mitotic and mitotic cells (7). The former
cells settle in the dentate plate (DP) scaffold, where deposition of
these pioneer granule cells begins in the suprapyramidal limb and
proceeds into the infrapyramidal limb, establishing the suprapyramidal-to-infrapyramidal morphogenic gradient of DG
scaffolding. The migrating mitotic granule cell precursors are destined
for the tertiary germinative matrix in the hilar region, which
constitutes an ectopic proliferative zone that persists into early
postnatal development giving rise to the majority of post-mitotic
granule cells that settle in the DP in the late embryonic and early
postnatal period. Deposition of late born granule neurons in the DP
follows an "outside-in" rule in which the youngest post-mitotic
cells are located in deep layers next to the hilar region, and older cells are located in superficial layers close to the outer molecular layer (7). During the 1st month of postnatal development, the tertiary
germinative matrix is replaced by the subgranular zone that forms at
the border between the hilus and the granule cell layer and which is
the major site of DG neurogenesis in adults.
As a first step toward identifying factors that might be involved in
defining hippocampal territory during early development, we describe
the identification and preliminary characterization of a novel
BTB/POZ-zinc finger gene, designated HOF. Alternative splicing gives rise to two protein isoforms that are nuclear, can
dimerize with each other, and bind specifically to DNA. In the
developing cerebral cortex, HOF expression is confined to neurons of
the presumptive hippocampus and is transiently up-regulated in immature
post-mitotic neurons derived from the hippocampal neuroepithelium and
dentate notch. Postnatally, HOF expression was observed in a
subpopulation of subventrical zone progenitors, in glial cells, and in
developing cerebellar granule cells.
 |
EXPERIMENTAL PROCEDURES |
Cell Culture--
The semi-differentiated oligodendrocytic cell
lines 6E12 and 2H5 were established from the spinal cord (8) and the
brain,2 respectively, of
transgenic mice expressing the SV40 large T-antigen in oligodendroglia
(9). The 2H5 and 6E12 cell lines were cultured in Dulbecco's modified
Eagle's medium supplemented with 2% fetal bovine serum as described
previously (8). Cortical primary cells were prepared by dissociation of
medial temporal lobes from embryonic day 18 mice, and cells were plated
on poly-D-lysine-coated coverslips for 2 days in
Dulbecco's modified Eagle's medium containing 10% fetal bovine
serum, 0.1 IU/liter insulin, 7.3 µM
p-aminobenzoic acid, and 50 IU/liter penicillin.
Library Screening and Plasmid Constructions--
First-strand
cDNA was prepared from poly(A)+ RNA from the 2H5 cell
line. Hybridization of 400 ng of 2H5 cDNA with 13 µg of poly(A)+ RNA from the 6E12 cell line was followed by
chemical cross-linking and labeling as described previously (10), to
generate a subtracted single-stranded cDNA hybridization probe.
Approximately 80,000 clones from a non-amplified 6E12 cell cDNA
library (10) were screened by hybridization to the subtracted probe.
From the primary screening, 60 clones were pooled and rehybridized to
the same probe. Of these, 40 clones hybridized in a reproducible manner to the subtracted probe. Positive phage clones from the secondary screening were excised as pZL1 plasmid clones (Invitrogen). The cDNA insert of the clone encoding HOF was labeled by random priming and used to screen the 6E12 cDNA library or a mouse genomic DNA library in
Fix II (Stratagene). DNA sequencing was performed using
the dye terminator method and an automated sequencer (Amersham Biosciences). PCRs carried out on genomic DNA using Advantage 2 Polymerase (CLONTECH) and restriction digests of
positive
clones were cloned in pBluescript (Stratagene) or
pCR4-TOPO (Invitrogen) for sequencing.
To construct the plasmid Koz-L, the open reading frame of
HOFL was amplified with Pfu Turbo polymerase
(Stratagene) using a 5' primer that introduced a NotI site
and a Kozak consensus sequence before the first ATG
(5'-GCGGCCGCCACCATG-3'), together with a 3' primer which
introduced a SalI site after the stop codon, and the
resulting product was cloned into pBluescript. The open reading frames
for HOFS and HOFL were PCR-amplified and cloned
into the SmaI and NotI sites of pGEX-6P-2
(Amersham Biosciences). For expression of GST-HOF/Fingers, a PCR
product encoding amino acids 573-741 of HOFL was cloned
into the EcoRI and SalI sites of pGEX-6P-2.
Protein Studies and Western Blot Analysis--
Whole cell
extracts were prepared by homogenizing cells from a confluent
75-cm2 dish in 100 µl of RIPA buffer containing 450 mM NaCl and 0.2% v/v protease inhibitor mixture (Sigma).
After a 30-min incubation on ice, the extracts were spun at 14,000 × g for 10 min at 4 °C, and the supernatant was
recovered. Nuclear extracts were prepared from nuclear pellets,
obtained after removing the cytoplasmic extract with hypotonic buffer,
as above. Protein concentration was measured using Bio-Rad dye reagent,
and 10 µg of each extract was loaded on a 4-12% Tris glycine gel
(NOVEX). Western blots were probed with affinity-purified anti-HOF
(1:5000 dilution) using Western Breeze (NOVEX). The HOF polyclonal
antibody was raised in rabbits against a peptide epitope
(CPAKFDQIEQFNDHMR) located in the C-terminal end of HOF.
[35S]Methionine-labeled proteins, prepared using HOF-S,
HOF-L, or Koz-L plasmids or vector alone with the T7 coupled
Transcription/Translation system (Promega), were run in adjacent lanes
and subjected to autoradiography.
Induction of GST fusion protein expression in Escherichia
coli BL21 codon + RIL cells (Stratagene) and binding to
glutathione-Sepharose beads were carried out using standard procedures
(Amersham Biosciences). Beads with bound GST or GST fusion protein (2 µg) were incubated with 2.5 (HOFS) or 5 µl
(HOFL) of [35S]methionine-labeled protein in
200 µl of BB binding buffer (20 mM HEPES, pH 7.4, 100 mM KCl, 5 mM EDTA, 5 mM EGTA, 10%
glycerol (v/v), 0.4% Nonidet P-40, 1 mM dithiothreitol,
and 15% BSA (w/v)) for 1 h at room temperature. The beads were
washed twice in BB + 10% BSA, three times in BB + 5% BSA, and three
times in BSA-free BB. Bound proteins were released by boiling in SDS
sample buffer and resolved on a 4-12% Tris glycine gel (NOVEX)
followed by autoradiography.
Yeast Two-hybrid System--
The open reading frames for
HOFS and HOFL were PCR-amplified and cloned in
frame with the DNA binding domain of GAL4 in pGBKT7 (CLONTECH). The regions encoding the POZ domains of
HOFS (amino acids 1-127) and HOFL (amino acids
1-200) were PCR-amplified and cloned in frame with the activation
domain of GAL4 in pGADT7 (CLONTECH). The pGBKT7 and
pGADT7 derived plasmids were co-transformed into the yeast strain AH109
and maintained by growth in media lacking leucine and tryptophan.
Reporter gene expression was tested by spotting ~500 cells from each
co-transformant on selective media in the absence of histidine and
adenine and in the presence of X-
-galactosidase (CLONTECH).
DNA Binding Studies--
A pool of double-stranded oligomers
containing a random 20-mer in the middle was prepared as described
(11). Binding reactions were carried out with 500 ng of nonradioactive
oligomers and 2 µg of GST-HOF/Fingers protein bound to
glutathione-Sepharose beads in a buffer containing 25 mM
Tris-HCl, pH 7.9, 0.5 mM EDTA, 50 mM KCl, 5 mM MgCl2, 100 µM
ZnCl2, 5% Ficoll 400 (w/v), 0.1% Nonidet P-40 (v/v), 1 mM dithiothreitol, 100 µg/ml BSA (w/v), and 200 ng of
poly(dI-dC) (buffer A). After four rounds of selection and PCR-based
amplification of recovered DNA sequences (11), the resulting DNA was
radioactively labeled by incorporation of [
-32P]dCTP
(3000 Ci/mmol) and used in electrophoretic mobility shift assay (EMSA)
with GST or GST-HOF/Fingers protein. The retarded complex seen
specifically with the fusion protein was cut off the gel, eluted, and
cloned in the pCR4-TOPO vector (Invitrogen). A total of 25 clones were
sequenced. Because no obvious consensus was derived, double-stranded
oligonucleotides corresponding to the sequences shown in Fig.
2C and containing 5'-TCGA overhangs were synthesized.
Double-stranded oligonucleotides were labeled by filling in overhangs
with [
-32P]dCTP using the Klenow fragment of DNA
polymerase I. EMSA assays were carried out as previously described (12)
with 1 µg GST-HOF/Fingers protein and 6.5 ng labeled PLZF probe in
buffer A containing 1 µg poly(dI-dC) per reaction. Where indicated, a
10 min preincubation of protein with cold competitor double-stranded
DNA (100 ng) was included. Samples were loaded onto a 6%
polyacrylamide gel (NOVEX) with 0.5 × TBE running buffer (45 mM Tris borate, pH 8.3, 1 mM EDTA).
Electrophoresis was carried out (100 V, 1-2 h), and the gel was dried
and subjected to autoradiography.
Immunohistochemistry and in Situ Hybridization--
For
immunohistochemistry, brains were removed from mice and immediately
frozen in liquid N2. Cryosections (30 µm) were collected on gelatinized glass slides, fixed with methanol for 5 min, and preincubated for 15 min in phosphate-buffered saline containing 2% BSA
to reduce background. Cells grown on coverslips were washed twice with
phosphate-buffered saline before being subjected to immunohistochemistry.
Immunohistochemistry was carried out as described previously, using
phosphate-buffered saline, 2% BSA as the antibody diluent (13). The
primary antibodies used at 1:100 dilution are mouse 2',3'-cyclic
nucleotide 3'-phosphodiesterase (CNCase; Neomarkers), mouse NeuN
(Chemicon), rabbit glial fibrillary acidic protein (GFAC;
Sigma), rabbit c-Myc (Santa Cruz Biotechnology), rabbit Oct-6 (a kind
gift from Michael Wegner), and rabbit HOF antisera. For staining with
sheep bromodeoxyuridine antisera (1:200 dilution, Research
Diagnostics), the fixed sections were first treated for 30 s each
with 2 M HCl and 0.1 M borate. Primary
antibodies were detected with fluorescein isothiocyanate- or
tetramethylrhodamine B isothiocyanate-conjugated swine anti-rabbit,
7-amino-4-methylcoumarin-3-acetic acid-conjugated goat
anti-rabbit, fluorescein isothiocyanate-conjugated goat anti-mouse
(DAKO), and donkey anti-sheep (Research Diagnostics Inc.) secondary
antibodies at 1:80 dilution. In situ hybridization with an
alkali phosphatase-conjugated oligonucleotide probe
(5'-XTCAGCTGTCTTGGGTTTCTTCCGTTCTAGC-3', DNA Technology) was carried out
as described previously (10).
 |
RESULTS |
Cloning and Characterization of Two HOF Isoforms--
The cDNA
encoding the novel BTB/POZ domain factor, HOF, was isolated by a
subtractive cloning technique originally aimed at identifying novel
mRNAs expressed in brain oligodendroglia (see "Experimental
Procedures"). The HOF cDNA was used to rescreen an
oligodendrocyte cDNA library, resulting in the identification of
several alternately spliced cDNAs that yield two protein products, HOFL and HOFS. The HOF-L1 cDNA is 2990 bp
long and contains one long open reading frame from nucleotides
359-2584, encoding HOFL which has a deduced length of 741 amino acids (Fig. 1A). The HOF-S1 cDNA is 2760 bp long and contains one long open reading frame of 668 amino acids from nucleotides 370-2376, encoding
HOFS. The predicted HOFS translation product is
identical to amino acids 74-741 of HOFL but lacks the
N-terminal 73 amino acids of HOFL (Fig. 1A). The
N and C termini of both HOF protein isoforms have homology with BTB/POZ
domain zinc finger proteins (Fig. 1A). In addition, the
HOFL and HOFS translation products are 97%
identical to human homologs (GenBankTM accession numbers
AAG28340 and CAB43377, respectively).

View larger version (78K):
[in this window]
[in a new window]
|
Fig. 1.
Cloning and characterization of two HOF
isoforms. A, schematic representation of the two
protein isoforms of HOF deduced from cDNAs isolated from an
oligodendrocyte cDNA library. The N-terminal region of both HOF
isoforms contains a POZ domain and the C-terminal region contains five
C2H2 zinc fingers (ZnF).
HOFS lacks the N-terminal 73 amino acids present in
HOFL but is otherwise identical to HOFL.
B, in vitro coupled transcription/translation
(TNT) of HOF-S1 cDNA results in a single
major protein product, whereas translation of HOF-L1 cDNA results
in a protein of the same size as HOFS as well as a larger
product. Translation of two cDNA templates with an optimized Kozak
consensus around the first ATG of HOFL (Koz-L)
resulted in improved expression of the long isoform. Western blotting
of 6E12 and 2H5 cell extracts with a polyclonal antibody against HOF
resulted in two bands, which were also present in 6E12 nuclear extracts
(NE) but not in HeLa cell extracts. The two bands identified
by Western blotting co-migrate with in vitro translated
HOFL and HOFS when run on the same protein gel
(data not shown). C, comparison of the HOF BTB/POZ domain
with homologous BTB/POZ domain proteins. Identical residues are
highlighted with dark gray and similar residues with
light gray boxes. D, in vitro
[35S]methionine-labeled HOFS or
HOFL was incubated with the indicated GST fusion proteins
bound to glutathione-Sepharose beads, and the bound protein was eluted
and analyzed on a protein gel. E, the AH109 yeast strain was
co-transformed with plasmids encoding the indicated DBD and activation
domain (AD) fusion constructs and maintained in the absence
of leucine and tryptophan. Approximately 500 cells from each
co-transformant were plated on selective plates to test for reporter
gene expression. Interaction between the two hybrid proteins leads to
yeast growth in the absence of histidine and adenine and blue coloring
on X- -galactosidase (X- -gal). F,
schematic representation of the DBD and AD fusion constructs used in
E.
|
|
In vitro transcription-coupled translation of HOF-S1
cDNA gave a single major translation product, whereas translation
of HOF-L1 cDNA resulted in a protein of the same size as
HOFS as well as a larger product (Fig. 1B). We
hypothesized that the suboptimal translational context of the
HOFL start codon (TGACAAATGC) compared with the
consensus derived by Kozak (GCC(A/G)CCATGG), might result
in translational initiation of both HOFL and
HOFS isoforms from the HOF-L1 cDNA template due to
leaky ribosomal scanning (14), resulting in expression of two products.
When the region around the start site of HOFL was mutated
to GCCACCATGC, thus closer to the Kozak consensus, translation of HOFL was indeed improved (Fig.
1B, Koz-L) and the relative amount of the long
form was improved from 43 to 68%, supporting the hypothesis that the
short HOFS isoform is generated in addition to
HOFL from the HOF-L1 transcript by a leaky scanning
mechanism (Fig. 1B). Improved translation from the Koz-L
construct relative to HOF-L1 may also result from the removal of the
5'-untranslated region of HOF-L1.
To detect endogenous HOF proteins, a polyclonal antibody
was raised against a peptide located in the C-terminal end of HOF, whose sequence was identical with that of the human homolog. Because HOF was originally cloned from a 6E12 cell cDNA library, we
examined the oligodendrocytic cell lines 2H5 and 6E12 for HOF
expression by Western blotting. As shown in Fig. 1B, Western
blotting identified two major bands in these cell lines, which
co-migrated with the HOFL and HOFS bands
obtained by in vitro translation (Fig. 1B and
data not shown). The same two bands were also evident in nuclear
extract from 6E12 cells, indicating that both HOF isoforms are present in the nucleus (Fig. 1B). The HOF antibody was shown to be
specific because no bands were observed in Western blots of HeLa cell
extracts (Fig. 1B). Interestingly, in protein extracts from
the 2H5 and 6E12 cells there appears to be more protein corresponding
to the small HOF isoform than the large (Fig. 1B).
The N-terminal region of HOF contains a BTB/POZ domain that has about
36% overall amino acid homology to the BTB/POZ domains of
BCL-6, a potential oncogene involved in
chromosomal translocations in a third of diffuse large cell
lymphomas (15); BAZF, which is a
BCL-6 homologous gene of unknown function (16);
PLZF, whose chromosomal translocation is involved in
acute promyelocytic leukemia (17); and Miz-1, a c-Myc-interacting
protein containing 13 C2H2 zinc fingers (18)
(Fig. 1C).
BTB/POZ-zinc finger factors are often found in huge multimeric
complexes within the cell nucleus, and the BTB/POZ domain is thought to
represent the major protein-protein interaction interface on these
proteins (19). Hence, physical interaction between HOFS and
HOFL proteins was investigated in vitro by GST
pull-down experiments. GST fusion proteins were generated with
full-length HOFS and HOFL proteins (Fig.
1D). Approximately equal amounts of each of these fusion
proteins as well as GST alone were used in pull-down assays with
35S-labeled in vitro translated full-length HOF.
As shown in Fig. 1D, full-length HOFS and
HOFL can interact strongly in both homotypic and
heterotypic interactions. In further experiments designed to localize
the interaction interface, the yeast two-hybrid system was used to test
for an interaction between full-length HOFS or
HOFL and either the short or the long BTB/POZ domains (Fig.
1E). Yeast growth on selective plates lacking histidine and
adenine was observed when the activation domain (AD) fusion protein
with full-length HOF protein was expressed together with the
DNA-binding domain (DBD) fusion protein of either POZ domain. We
conclude that both HOF isoforms can engage in homo- and heterotypic
protein interactions and that the BTB/POZ domain seems to constitute a
major interaction interface.
The C-terminal region of HOF contains five C2H2
zinc finger motifs, where the fifth and most C-terminal zinc finger is
isolated from the proximal zinc fingers by a 32-amino acid linker (Fig. 1A). Because four zinc fingers are clustered and connected
by a conserved stretch of seven amino acids (the His-Cys link), HOF can
be assigned to the Krüppel-like subfamily of zinc fingers (20).
Notably, this region of HOF shares 55% similarity (41% identity) to
zinc fingers 4-7 of PLZF (17), indicating that the four proximal zinc
fingers of HOF may bind a related DNA sequence to PLZF (Fig.
2A). To test this hypothesis,
the DNA-binding site for PLZF (11) was used in an EMSA. As can be seen
in Fig. 2B, a GST fusion protein with HOF zinc fingers
(GST-HOF/Fingers), but not GST alone, gives a retarded band in EMSA
analysis when the PLZF-binding site is used as radioactively labeled
DNA probe (compare 1st and 2nd lanes). This
binding is essentially competed away by a 15-fold excess of cold
competitor DNA for PLZF (3rd lane) or S63 (7th
lane), a DNA sequence isolated by a PCR-based binding site
selection (11). There is little or no competition by the other DNA
oligonucleotides tested (lanes 4-6). In conclusion, a GST
fusion protein with the five zinc fingers of HOF binds specifically to
both PLZF and S63 sequences, which contain an identical 5-bp sequence
(Fig. 2C, underlined).

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 2.
Characterization of HOF DNA binding
activity. A, comparison of the four clustered zinc
fingers of HOF with fingers 4-7 of PLZF, with which they share the
greatest similarity (55%). The Cys and His residues of the zinc finger
motif are underlined. Identical residues are
highlighted with dark gray and similar residues
with light gray boxes. The arrow indicates the
position of the intron in the corresponding HOF genomic
sequence. B, EMSA analysis using GST or a GST fusion protein
with the zinc fingers of HOF (GST-HOF/Fingers) and a
radioactive PLZF probe. A 15-fold excess of cold competitor was
included as indicated. The position of the DNA-protein complex is
indicated on the left. C, the sequences of the
top strand for each double-stranded oligonucleotide and a summary of
the competition results in B are shown. Both PLZF and S63
oligonucleotides compete well for binding and contain an identical 5-p
sequence (underlined).
|
|
In addition to HOF-L1 and HOF-S1, six additional alternative splice
forms of HOF were identified by screening the oligodendrocyte cDNA
library (Fig. 3A). All HOF-L
cDNAs are ~3000 nucleotides long and contain one long open
reading frame identical to HOFL (Fig. 1A). The
HOF-S cDNAs are about 2700 bp long and contain one long open
reading frame identical to HOFS (Fig. 1A). To
understand how these splice variants are generated, the mouse genomic
locus for HOF was characterized (Fig. 3B). Of the
11 exons that we identified, only exons II and V-VII were present in
all splice forms. There are four alternative sequences in the most 5'
ends of the oligodendrocyte-derived cDNAs, which are derived from
exons ID-1 and ID-2 spliced together or exons IA-C individually (Fig.
3). Expressed sequence tags in the GenBankTM data base
suggest further complexity in the 5'-untranslated region, but none of
these give rise to new protein isoforms. The human genomic locus
corresponding to mouse exons ID-1 to VII covers 313 kb, although if
expressed sequence tags are taken into account, the locus exceeds 700 kb. The mRNAs coding for HOFS lack exon IV, which
contains the translation initiation codon for HOFL, and
utilize instead a downstream in-frame ATG codon in exon VI,
corresponding to nucleotides 578-580 in HOF-L1 (Fig. 3B). The intron between exons VI and VII is located at nucleotides 2162-2163 in HOF-L1, which corresponds to the linker region between the first and second zinc finger (Fig. 2A,
arrow). Thus, the BTB/POZ domain and the first zinc finger
is encoded by exon VI and the four C-terminal zinc fingers by exon
VII.

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 3.
Alternative splice forms and genomic
structure of HOF. A, schematic representation of the
alternative HOF splice forms isolated by screening an oligodendrocyte
cDNA library with HOF cDNA. The start codon is indicated by an
arrow and the stop codon by an asterisk. Exons
are depicted as boxes, and filled boxes are
coding. B, genomic structure of the HOF locus in
mice, drawn to scale. The dotted lines indicate regions that
have been sequenced on genomic DNA. Double slanted lines
indicate introns of undetermined length.
|
|
HOF Expression Coincides with Hippocampal Neurogenesis--
To
identify HOF expression in the developing brain, we performed
immunohistochemistry (Fig. 4,
A-F) and in situ hybridization (Fig. 4,
G-J) on sections of mouse brains. This procedure showed that during late embryonic and postnatal development of the cerebral cortex, HOF expression is mainly confined to presumptive CA pyramidal and DG granule neurons of the hippocampal subdivision (Fig. 4, B
inset, and G). Generation of post-mitotic Ammon's horn
precursor neurons from progenitor cells in the hippocampal
neuroepithelium begins around embryonic day 11 (E11), and the first CA
field-specific differentiation markers identified in these cells appear
around E15 (21). At E16.5, HOF is expressed in a broad band of neurons constituting the intermediate zone (or inferior band) of the
hippocampal anlagen (Fig. 4A). At E18.5, HOF appears in both
migrating and settled pyramidal precursor neurons of the inferior band
and the HP, respectively (Fig. 4B). The first granule cell
precursors migrate out from the DG neuroepithelium around the dentate
notch at E17. From E18.5 and until birth, numerous HOF-expressing cells were observed in the migratory path from the dentate neuroepithelium to
the DG, and at least a subpopulation of these HOF-positive cells
appears to be the so-called scaffolding pioneer granule cells that
settle first in the suprapyramidal limb of the dentate anlagen,
establishing the suprapyramidal-to-infrapyramidal morphogenic gradient
(Fig. 4, B and C). During the end of the first
postnatal week, HOF expression was still pronounced in hippocampal
pyramidal and granule neurons (Fig. 4D). During postnatal
development, there is a clear gradient of HOF expression in which
highest levels occur in the newest born cells (Fig. 4, D,
arrow, and H), and there is a marked decline of
HOF expression in mature neurons expressing the neuronal
differentiation marker NeuN. A general decline in HOF expression
occurred in pyramidal neurons of Ammons horn during the 2nd postnatal
week and persisted into adulthood (Fig. 4, E, F,
I, and J). A similar decline in HOF expression occurred in the DG except for recently formed granule cells that settle
in a band along the hilar side of the DG (Fig. 4, E,
F, and I). The indusium griseum is a thin layer
of gray matter on the dorsal surface of the corpus callosum, which is
regarded as a rudimentary (or vestigial) portion of the hippocampus. As
shown in Fig. 4M, HOF expression was pronounced
in indusium griseum cells at E18.5.

View larger version (66K):
[in this window]
[in a new window]
|
Fig. 4.
Localization of HOF in the developing
cerebral cortex. Horizontal sections of mouse brains of E16.5
(A), E18.5 (B), P0.5 (C and
G), P5 (D), P7 (H), P14
(I), P15 (E), P28 (F), and adult
(J) mice were subjected to immunohistochemistry using
HOF-specific polyclonal antiserum (A-F) and to in
situ hybridization with an alkaline phosphatase-labeled probe
complementary to HOF mRNA (G-J). A and
B, HOF expression was confined to the archicortical
neuroepithelium lining the lateral ventricle, the hippocampal
intermediate zone, and the expanding hippocampal plate.
B, upper inset, saggital brain section showing
HOF expression is confined to the hippocampal territory
(circle) but not the adjacent neocortex. B,
lower inset, numerous HOF-expressing progenitors leave the
dentate notch (arrow) to migrate to the dentate gyrus.
C and G, in newborn mice, HOF expression appears
in migrating cells of the hippocampal intermediate zone and in cells
along the dentate gyrus migratory path, in presumptive pyramidal cells
settled in the CA1 and CA3 subregions of Ammon's horn as well as in
granule cells settled in the external blade of the dentate gyrus.
D and H, during the 1st postnatal week, HOF
expression is pronounced in settled neurons in Ammon's horn and
dentate gyrus. D, inset, double immunostaining
for the mature neuronal marker NeuN (green) and HOF
(red) shows that HOF is expressed at high levels in latest
born neurons in both the pyramidal cell layer (arrow) and
the granule cell layer. E and I, at the end of
the 2nd postnatal week, a decline in HOF expression was revealed in
pyramidal neurons of the Ammon's horn, whereas high levels of
expression occurred in newborn granule neurons lining the hilus
(arrow). E, inset, double NeuN
(green) and HOF (red) immunostaining showing high
HOF expression in less mature granule neurons (arrow).
F and J, after the 1st month of postnatal life, a
modest HOF expression appeared in Ammon's horn neurons and in granule
cells of dentate gyrus. K and L,
immunofluorescent staining of HOF and Oct-6, respectively, in
horizontal sections of E18.5 hippocampi showing that the two proteins
are co-expressed in migrating and settled CA1 cells
(circle). L, inset, in contrast to
HOF, Oct-6 is also expressed at high levels in the cortical plate of
the neocortex. M, expression of HOF (red) in the
indusium griseum of E18.5 mice. N-P, to identify actively
dividing cells in the hippocampus, E18.5 mice were analyzed by
immunohistochemistry after 3 h administration of BrdUrd. Note the
nuclear staining of HOF (red) and the lack of co-staining
with BrdUrd (green). The abbreviations used are as follows:
IZ, intermediate zone; LV, lateral ventricle;
HP, hippocampal plate; DN, dentate notch;
Hipp, hippocampus; SVZ, subventricular zone;
CP, cortical plate; CC, corpus callosum.
|
|
In addition to migrating post-mitotic cells in the inferior band and
settled cells in the HP, HOF is also expressed in cells scattered in
the ventricular and subventricular zone of the hippocampal neuroepithelium at E18.5 (Fig. 4K). These cells may be newly
born post-mitotic cells at their departure from the subventricular zone. Alternatively, they may represent a precursor cell population that is still dividing. In addition, the stream of HOF-expressing cells
leaving the dentate notch may be newly born post-mitotic cells
migrating to the DG to form the granule cell layer as well as mitotic
precursor cells migrating to the DG to establish the tertiary
germinative matrix (7). To test these various possibilities, the
pattern of BrdUrd labeling was examined in E18.5 embryos after administration of BrdUrd 3 h before killing. This short time frame ensures that only actively dividing or very recent post-mitotic cell
populations were labeled. Using BrdUrd labeling and immunohistochemical localization, we were unable to detect BrdUrd and HOF double-labeled cells in the hippocampal subventricular zone (data not shown) or along
the DG migratory path (Fig. 4, N-P). Thus, HOF is unlikely to be expressed in the nuclei of dividing precursor cells in the developing hippocampus. Taken together, the analyses described above
show that HOF is transiently up-regulated in immature post-mitotic neurons derived from the hippocampal neuroepithelium.
Previous studies have shown that cells in the hippocampal
neuroepithelium and CA fields express specific molecular markers during
early cortical development prior to the arrival of hippocampal afferents, and overt morphological differences become apparent between
CA1 and CA3 neurons (22, 23). Thus it is highly likely that hippocampal
neurons are specified early, presumably through the influence of
patterning centers (21, 24). One of the earliest markers of CA1 field
specification in the hippocampus is the POU homeodomain transcription
factor Oct-6, the RNA of which appears in cortical plate neurons and in
presumptive CA1 neurons as early as E15.5 (22). In line with this, we
detected Oct-6 protein in immature CA1 neurons in the inferior band and
the hippocampal plate at E18.5 as well as in developing pyramidal
neurons of the cortical plate but not in cells of the CA3 field and DG
(Fig. 4L). Thus, HOF and Oct-6 proteins exhibit a distinct
co-expression domain in presumptive CA1 neurons during cortical
neurogenesis (Fig. 4, K and L).
HOF Is Transiently Expressed during Granule Cell Development in the
Cerebellum--
During postnatal brain development, HOF expression
occurs transiently in the granule cell layer of the cerebellum (Fig.
5). Cerebellar granule cells are born
postnatally in the external granular layer (EGL), and these
post-mitotic precursor cells migrate inward through the molecular layer
along the processes of radial Bergman glia to settle in the internal
granule cell layer (IGL). In the mouse, the majority of cerebellar
granule cells are generated during the first 3 weeks of postnatal
development (25, 26). By using immunohistochemistry, we investigated
the pattern of HOF expression during cerebellar granule cell
neurogenesis. At P5 and P10, the EGL has expanded beneath the pial
surface, and only a small number of granule cells have completed their
migration along Bergman glia and initiated expression of the mature
neuronal marker NeuN (Fig. 5, A and B). HOF
expression appears diffuse in the EGL and is not confined to nuclei. On
the contrary, a distinct nuclear HOF staining is apparent in immature
granule cells residing transiently in a layer in the upper aspect of
the IGL (Fig. 5, A-C). These cells may correspond to the
population of brain-specific lipid-binding protein expressing immature
granule cells described previously (25). HOF expression in the IGL
seems to coincide with immature granule cells that appear not to
express the mature neuronal marker NeuN (Fig. 5B). The EGL
is a transitory structure, which in the mouse ceases to exist by the
end of the 3rd postnatal week at which time numerous granule cells
populate the expanding IGL (26). At P15, HOF expression in the
molecular layer is restricted to a narrow band of cells lining the pial
surface as well as to scattered cells along the migratory path to the
IGL (Fig. 5D). In addition, numerous presumptive granule
cell precursors express HOF in the IGL, and only a minor portion of
these appear to co-express NeuN (Fig. 5E). During the
following week, HOF expression in the IGL and molecular layer declined
and was confined to only a few scattered cells (Fig. 5F).
Taken together, this preliminary expression analysis indicates that HOF
is transiently up-regulated in the nuclei of migrating granule cell
precursors and that expression of the gene is extinguished as granule
neurons mature in the IGL.

View larger version (95K):
[in this window]
[in a new window]
|
Fig. 5.
HOF expression in cerebellar granule
cells. Immunofluorescent detection of HOF (red) in
horizontal sections of mouse cerebellum from P5 to P28.
A-C, during the 1st 2 postnatal weeks, HOF immunostaining
was revealed in the nuclei of immature granule neurons migrating in the
molecular layer, sojourning in a transient layer in the upper aspect of
the IGL (arrow) as well as in scattered cells in deeper
layers of the IGL. Note that HOF expression in the EGL is not confined
to nuclei, and cells expressing HOF (red) in the IGL do not
co-express the mature neuronal marker NeuN (green).
D and E, after the 2nd postnatal week, the EGL
has ceased to exist, and HOF expression (red) is confined to
numerous cells that have settled in the IGL. Note that only a minor
portion of the cells seems to co-express NeuN (green).
F, at late stages of cerebellar development (P28),
expression of HOF in the granule cell layer has declined, and staining
is confined to a few scattered cells. The abbreviations used are as
follows: wm, white matter; egl, external granule
cell layer; igl, internal granule cell layer; ml,
molecular layer; gcl, granule cell layer.
|
|
HOF Is an Early Marker for Astrocytes in the Subventricular Zone
and Rostral Migratory Stream--
The subventricular zone (SVZ) of the
lateral ventricle generates macroglia and olfactory bulb interneurons
during postnatal brain development (27, 28). The latter cells migrate
several millimeters along the rostral migratory stream (RMS) to the
olfactory bulb, where they settle in the granule cell layer and
glomerular layer (29). As shown in Fig.
6, A and B, HOF
expression appeared in cells lining the entire SVZ implying that HOF
may be an early marker for postnatal gliogenesis and/or neurogenesis.
In addition, a pronounced HOF expression appeared in a subpopulation of
cells in the anterior SVZ (aSVZ, Fig. 6C). Stem
cells in this region are considered by some authors to be a
homogenous population giving rise to mainly olfactory bulb
granule neurons and periglomerular neurons (30, 31). Thus, HOF may be
an early marker for these specialized neurons. Moreover, numerous
astroglia are present in the RMS and the olfactory bulb during
postnatal development, but little attention has been put to
the origin of these non-neuronal cells (32, 33). By using
immunohistochemistry, we decided to determine the fate of HOF-positive
cells migrating in the RMS. At P5, a subpopulation of cells in the
anterior SVZ express HOF (Fig. 6C). As was expected for
undifferentiated SVZ cells, these HOF-positive cells do not express the
astroglial differentiation marker GFAP nor the neuronal differentiation
marker NeuN (data not shown). At P15, expression of HOF is pronounced
in cells migrating in the RMS and in cells scattered throughout the
olfactory bulb (Fig. 6, D-F and H).
In the olfactory bulb glomerular layer, HOF expressing cells are found
mainly at the periphery of individual glomeruli with a few positive
cells at the center (Fig. 6F). Immature interneurons
migrating in the RMS do not express NeuN, as opposed to mature neurons
in the granule cell layer that express the neuronal differentiation
marker (Fig. 6G). In the granule cell layer, there is a
clear non-overlapping expression of NeuN and HOF (Fig. 6, I
and K), indicating that HOF is either expressed in
non-neuronal cells in this layer or in immature interneurons. However,
the scattered appearance of HOF-positive cells in most layers of the olfactory bulb and the observation that only a subpopulation of cells
in the RMS express HOF (Fig. 6J) strongly imply that the protein is expressed in astroglia. To test this possibility, we performed double immunohistochemistry with HOF and GFAP antibodies. As
shown in Fig. 6L, the majority of HOF-positive cells in the RMS and granule cell layer express the astroglial marker GFAP. In
addition to the olfactory bulb, HOF is also a marker for astroglia in
other brain locations including the cerebral cortex and cerebellum (Fig. 7, A and B).
Taken together, these results suggest that HOF is an early SVZ marker
for glial precursor cells. Furthermore, our data indicate that the
anterior SVZ is a significant source of olfactory bulb astrocytes
migrating in the RMS.

View larger version (83K):
[in this window]
[in a new window]
|
Fig. 6.
HOF expression in subventricular zone
progenitor cells. A, horizontal section of neonatal
mouse olfactory bulb showing weak to moderate levels of HOF
immunostaining of cells in the rostral migration stream
(RMS) and glomerular layer. A, inset,
horizontal section of lateral ventricle subjected to in situ
hybridization with an alkaline phosphatase-labeled probe complementary
to HOF. Note the strong staining of cells at the anterior
(arrow) and posterior regions of the subventricular zone.
B and C, horizontal sections of the lateral
ventricle of P5 mouse brains, stained with an HOF-specific antibody
(red), showing pronounced HOF expression in subventricular
zone cells at the most anterior-posterior levels. Note that HOF
(red) seems to define a subpopulation of cells
(DAPI) in the anterior subventricular zone (C).
D and E, saggital sections of P15 mouse brains
subjected to HOF (red) immunostaining. Note the numerous
HOF-positive cells migrating along the vertical limb of the RMS.
F, horizontal section through the olfactory bulb of P15
animal subjected to HOF (red) immunostaining. Note that
HOF-expressing cells are not confined to a single layer but are
scattered throughout most regions of the bulb. G-I and
K, horizontal sections through the olfactory bulb of P15
animal subjected to NeuN (green) and HOF (red)
immunostaining. G, olfactory bulb granule cells express the
mature neuronal marker NeuN. H, numerous cells in the
horizontal limb of the RMS express HOF as well as cells scattered in
the granule cell layer. I and K, cells expressing
HOF (red) in the granule cell layer do not co-express NeuN
(green). Note that specific NeuN staining is nuclear; the
streaky green staining is due to nonspecific binding. J,
saggital section of the olfactory bulb of P15 mouse showing co-staining
with DAPI (blue) and HOF (red). Note that HOF
expression is confined to a subpopulation of cells migrating in the
horizontal limb of the RMS. L, horizontal section of mouse
olfactory bulb of P15. Double immunostaining for GFAP
(green) and HOF (red) demonstrates that the
majority of HOF-positive cells in the RMS and GCL express the
astroglial marker GFAP. The abbreviations used are as follows:
OB, olfactory bulb; RMS, rostral migratory
stream; GL, glomerular layer; Str, striatum;
aSVZ, anterior subventricular zone; LV, lateral
ventricle; CC, corpus callosum; GCL, granule cell
layer; MCL, mitral cell layer; EPL, external
plexiform layer; ONL, outer olfactory nerve fiber layer;
DAPI, 4,6-diamidino-2-phenylindole.
|
|

View larger version (60K):
[in this window]
[in a new window]
|
Fig. 7.
HOF is expressed in macroglia.
A and B, double immunostaining of HOF
(red) and GFAP (green) in astroglia.
A, HOF-positive astroglia in primary cultures of cortical
cells established from the medial temporal lobe of E18 mouse embryos
co-express GFAP (green). B, in the white matter
(wm) of the cerebellum only a subpopulation of
HOF-expressing glial cells express GFAP. C, HOF expression
in the cerebellar white matter coincides with that of CNPase
(green), a marker for myelin-forming oligodendroglia.
D-F, co-staining of the fornix with
DAPI (blue) and HOF (red) demonstrates
that HOF-expressing cells in white matter tracts are present in long
arrays characteristic of oligodendroglia. G and
H, nuclear HOF expression is observed in 2H5 and 6E12
oligodendrocytic cells, respectively. Many, but not all, 6E12
oligodendrocyte cells exhibit a characteristic speckled nuclear
staining (arrows). I, double immunostaining of
6E12 cells incubated for 2 h in the presence of BrdUrd with HOF-
(red) and BrdUrd (green)-specific antibodies. HOF
expression was occasionally detected in DNA-replicating cells
(yellow, arrows). J-L, to investigate
whether HOF expression coincides with proliferation of gliogenic
progenitor cells, the pattern of HOF expression was revealed in the
gliogenic subventricular zone of the fimbria in E18.5 mice killed
3 h after administration of BrdUrd. Note the lack of cells
exhibiting double immunostaining for HOF (red) and BrdUrd
(green). DAPI,
4,6-diamidino-2-phenylindole.
|
|
HOF Is Expressed in Oligodendroglia and in Reactive Astroglia
during Brain Pathology--
As described above, a pronounced HOF
expression was revealed in the postnatal subventricular zone of the
lateral ventricle. This zone harbors numerous glial precursor cells,
which give rise to both astrocytes and oligodendrocytes (27). HOF
expression is prominent in white matter tracts (Fig. 7, C
and D), which are enriched in glial cells and do not contain
neuronal cell bodies. However, only a subpopulation of HOF-expressing
cells in white matter expresses the astroglial marker GFAP (Fig.
7B), indicating that HOF is also expressed in
oligodendrocytic cells in vivo. The domain of HOF expression
coincides with that of CNPase, an oligodendrocytic marker (Fig.
7C). A notable feature of HOF-expressing glial cells in
white matter tracts such as the fornix is that they are localized in
long arrays characteristic of oligodendroglia (Fig. 7,
D-F). Moreover, Western blots show that both
HOF isoforms are expressed in two oligodendrocytic cell lines (Fig.
1B), and immunocytochemistry with the HOF antibody revealed
uniform nuclear staining of HOF protein in 2H5 oligodendrocytic cells
(Fig. 7G). However, staining for HOF in 6E12
oligodendrocytic cells showed a speckled nuclear staining pattern in
many but not all cells (Fig. 7H), implying that HOF is
concentrated in nuclear subdomains in these cells. Interestingly,
several other BTB/POZ domain proteins have been found to display
speckled nuclear localization, which presumably is related to the
ability of these proteins to interface in higher molecular weight
complexes (34).
In 6E12 cells, expression of HOF was detected in replicating cells
labeled for 2 h with BrdUrd prior to staining (Fig.
7I). To test the possibility that HOF is also expressed
during DNA replication of gliogenic stem cells, the pattern of BrdUrd
labeling was revealed in progenitor cells in the fimbrial
subventricular zone in E18.5 embryos after administration of
BrdUrd 3 h before killing. This portion of the subventricular zone
generates glial stem cells populating the fimbria/fornix during
hippocampal development (4). As shown in Fig. 7, J-L, we
were unable to detect HOF expression in BrdUrd-labeled stem cells in
the fimbrial subventricular zone. Thus, we conclude that HOF expression
coincides with post-mitotic development of glial cells in this area.
By having demonstrated HOF expression in macroglia, we next
investigated whether the protein is expressed in glial cells during brain pathology. In these experiments, we analyzed brains from transgenic mice in which c-Myc is ectopically expressed in
myelin-forming oligodendroglia under control of a myelin basic protein
promoter (Fig. 8A). Affected
transgenic mice develop a hypomyelinating phenotype characterized by
untimely programmed cell death of oligodendroglia (13, 35).
Immunostaining of white matter tracts with CNPase reveals multiple
hypomyelinated lesions in c-Myc transgenic mice compared with control
mice (Fig. 8, B and C). These hypomyelinated lesions are populated by numerous GFAP-positive astrogliotic cells, which are enlarged relative to those present in the fornix of control
mice (Fig. 8, E and H). To test whether HOF is
expressed in these activated astrocytes, we have performed triple
staining of the fornix from c-Myc transgenic mice and controls (Fig. 8, F and I). HOF expression is pronounced in
GFAP-positive reactive astrocytes in lesioned areas (Fig.
8F, circle, purple). As mentioned above, HOF is also expressed in normal astrocytes in control animals (Fig. 8I).

View larger version (113K):
[in this window]
[in a new window]
|
Fig. 8.
HOF is expressed in reactive astrocytes.
Immunostaining of c-Myc, NeuN, CNPase, HOF, and GFAP in brain sections
from myelin basic protein/c-Myc transgenic mice (A and
B, and D-F) and control mice (C and
G-I) at P20. A, double c-Myc (red)
and NeuN (green) staining showing c-Myc transgene expression
in fimbrial oligodendroglia (arrow). B, CNPase
immunostaining of fornix showing pronounced hypomyelination
(circle). C, CNPase staining of fornix of
age-matched control mouse. D, expression of HOF
(blue) in lesioned fornix of myelin basic protein/c-Myc
transgenic mouse. E, double immunostaining for CNPase
(green) and GFAP (red) showing concentration of
reactive astroglia in lesioned area (circle). F,
triple immunostaining for CNPase (green), GFAP
(red), and HOF (blue) showing pronounced HOF
expression in reactive astroglia (pink) in hypomyelinated
area (circle). G-I, HOF (blue) is
co-expressed in GFAP positive astrocytes (red) in the fornix
of control mice.
|
|
 |
DISCUSSION |
Here we identify two isoforms of a new murine nuclear BTB/POZ
domain zinc finger factor, designated HOF, that is expressed in
hippocampal neurons, cerebellar granule neurons, and macroglia. Nuclear
BTB/POZ domain factors have been implicated in regulation of chromatin
conformation associated with cellular differentiation, including the
establishment of accessible (i.e. euchromatin) or inaccessible (i.e. heterochromatin) domains for classical
transcription factors (34). HOF expression coincides with early
post-mitotic development of the three principal hippocampal cell types,
presumptive CA1 and CA3 pyramidal neurons of Ammon's horn and
presumptive granule neurons of the dentate gyrus, and a sharp decline
in expression appears at the border between the CA1 region and the
subiculum. Although several genes are known to be expressed in
subdomains within the developing hippocampus (21, 23), HOF seems to be the first example of a gene whose expression is strictly confined to
neurons of the hippocampal territory as opposed to the adjacent neocortical and transitional areas. Thus, HOF is a candidate regulatory factor for hippocampal cell fate in the medial temporal lobe. Furthermore, the observation that HOF is expressed in all three major
neuronal cell types argues for a coordination function for the gene in
hippocampal development. The finding that HOF and the POU homeodomain
transcription factor Oct-6 are co-expressed in migrating and settled
CA1 neurons implies that HOF could function with such
subregion-restricted factors to specify neuronal subtype identities in
the hippocampus. Alternatively, HOF could exhibit a more global role
during hippocampal development such as a function in morphogenesis of
the single cell-layered stratum pyramidal and granule cell layer or in
coordination of hippocampal axon pathfinding.
In addition to the dentate gyrus, HOF was also expressed during
postnatal granule cell development in the cerebellum. Based on spatial
and temporal expression patterns of molecular markers, Heintz and
co-workers (25) defined four stages of development of cerebellar
granule neurons. The first stage is granule cell neurogenesis, which is
localized to proliferating cells in the superficial layer of the EGL.
The second stage is initiation of differentiation of young post-mitotic
cells in the deeper aspect of the EGL and extension of T-shaped
parallel fibers. The third stage of granule cell development ranges
from axon extension and migration along radial Bergmann glial processes
in the molecular layer to their settling in deeper layers in the IGL.
This stage is also characterized by the presence of a transient layer
of immature granule cells in the upper aspect of the IGL, at the level
of the Purkinje cell layer and the end of the radial glial trail. The
transient layer presumably marks a transition from glial to non-glial
guided migration and is characterized by expression of a brain-specific
lipid-binding protein in both radial Bergmann glia and granule cells
(25). The fourth stage is characterized by terminal differentiation of
settled granule cells in the IGL. This mature stage involves
establishment of connections between Purkinje cell dendrites and
parallel granule cell axons in the molecular layer as well as
connections between afferent mossy fiber axons and granule cell
dendrites in the IGL.
Moderate levels of HOF occur in EGL cells during the first 2 weeks of
postnatal development, but localization of the protein is not confined
to nuclei. On the contrary, a distinct nuclear staining was revealed in
immature granule cells which (i) migrate in the molecular layer, (ii)
sojourn in a transient layer in the upper aspect of the IGL, and (iii)
settle in deeper layers of the IGL. After the 2nd postnatal week,
expression of the gene was confined to immature granule cells of the
IGL but was down-regulated in mature granule cells. This expression
pattern corresponds to stage three of granule cell development
described above indicating that HOF may play roles in granule cell
migration and axon growth but less in processes associated with granule
cell proliferation (stage one) and refinement of synaptic connections
(stage four).
The postnatal subventricular zone lining the lateral ventricle is
thought to derive from the subventricular zone of the lateral ganglionic eminence (28). The latter generates tangentially migrating
cortical interneurons during embryonic neurogenesis (36, 37), whereas
the former is a major source of immature neurons migrating along the
RMS to the olfactory bulb, where they differentiate into granule and
periglomerular interneurons. In addition to olfactory bulb
interneurons, the postnatal subventricular zone also harbors gliogenic
stem cells, which generate astroglia and oligodendroglia. The anterior
subventricular zone was considered to be restricted to generation of
olfactory bulb interneurons, whereas more caudal levels were enriched
in gliogenic progenitors (27, 30). Recent studies have shown that
neuronal progenitors can be isolated from all rostro-caudal levels (38)
and that the subventricular zone is a continuum of migrating neurons
and astroglia arranged as chains in which some migrate tangentially from more caudal levels to join the RMS (28, 39). Moreover, although
numerous astrocytes migrate along the RMS to the olfactory bulb, little
attention has been put into the origin of these cells.
We find HOF expression at all rostro-caudal levels of the
subventricular zone, and this expression coincides with immature cells
that do not express astrocyte or neuronal late differentiation markers.
In addition, high levels of HOF were revealed in a major portion of
cells lining the anterior subventricular zone (Fig. 4C)
indicating that this region is not a homogenous cell mass but is a
patchwork of HOF-expressing and non-expressing cells. A similar
patchwork of HOF-expressing and non-expressing cells appeared in the
horizontal limb of the RMS. In the RMS, the great majority of these
HOF-positive cells appeared to be astrocytes as they express the glial
marker GFAP. Whether HOF expression in the anterior subventricular zone
occurs in a progenitor common to astroglia and olfactory neurons or in
cells already restricted to a glial fate remains to be determined.
Furthermore, HOF expression was also persistent in mature astroglia in
other locations including the striatum, the cerebral cortex, and
cerebellum as well as in white matter oligodendroglia indicating that
HOF-expressing subventricular zone progenitors give rise to at least
two types of mature glial cells. Whatever the case, this expression
pattern suggests that HOF is a candidate marker for gliogenic
progenitor cells in this region of the subventricular zone, including
more caudal regions, and that the RMS may be a significant source of
astroglia populating the olfactory bulb during postnatal development.
In Drosophila, several BTB/POZ domain zinc finger
transcription factors have been implicated in nervous system
development, including the involvement of the tramtrack
(ttk) gene in glial cell, sensory organ, photoreceptor, and
cone cell development (5, 40-45); the longitudinal lacking
(lola) gene in axon growth and path finding (46); the
abrupt (ab) gene in the formation of
neuromuscular connections and proper muscle attachments (47); and the
fruitless (fru) gene, which is expressed in a
subset of neurons in the development of proper male sexual behavior
(48-51). A number of mammalian BTB/POZ-zinc finger factors are
expressed in the central nervous system (52-57), but the functional
significance of this expression is not clear. In addition, the BTB/POZ
domain factors BCL-6/LAZ3 and PLZF have been implicated in human
malignancies involving chromosomal translocations (15, 58, 59). The
importance of BTB/POZ zinc finger factors in cell type specification in
the Drosophila nervous system implies that such factors also
play important roles in specifying neuronal and glial cell lineages in
the mammalian central nervous system. Thus, identification of novel
mammalian BTB/POZ factors is an important first step in understanding
their role in brain development. The cloning of the HOF gene
provides an opportunity to inactivate the gene by homologous
recombination. This could reveal definitive evidence regarding the role
of this gene product in mammalian brain development.
 |
ACKNOWLEDGEMENT |
We thank Malene B. Hansen for help with
establishment of primary cortical cultures.
 |
FOOTNOTES |
*
This work was supported by grants from the Lundbeck
Foundation, the Danish Cancer Society, Løvens Kemiske Fabriks
Foundation, the Michelsen Foundation, and the NOVO-Nordisk Foundation.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AF185576 and AF194030.
§
To whom correspondence should be addressed. Tel.: 45-35327722; Fax:
45-35327701; E-mail: naj@imbg.ku.dk.
Published, JBC Papers in Press, December 13, 2001, DOI 10.1074/jbc.M110023200
2
N. A. Jensen, unpublished data.
 |
ABBREVIATIONS |
The abbreviations used are:
DG, dentate gyrus;
BTB/POZ, broad complex tramtrack bric-a-brac/poxvirus and zinc finger;
HP, hippocampal plate;
DP, dentate plate;
GST, glutathione
S-transferase;
EMSA, electrophoretic mobility shift assay;
DBD, DNA-binding domain;
AD, activation domain;
PLZF, promyelocytic
leukemia zinc finger protein;
EGL, external granular cell layer;
IGL, internal granule cell layer;
SVZ, subventricular zone;
RMS, rostral
migratory stream;
BrdUrd, bromodeoxyuridine;
BSA, bovine serum albumin;
AD, activation domain.
 |
REFERENCES |
| 1.
|
Lisman, J. E.
(1999)
Neuron
22,
233-242[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Amaral, D. G.,
and Witter, M. P.
(1995)
in
The Rat Nervous System
(Paxinos, G., ed)
, pp. 443-493, Academic Press, San Diego
|
| 3.
|
Levitt, P.,
Barbe, M. F.,
and Eagleson, K. L.
(1997)
Annu. Rev. Neurosci.
20,
1-24[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Altman, J.,
and Bayer, S. A.
(1990)
J. Comp. Neurol.
301,
325-342[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Guo, M.,
Bier, E.,
Jan, L. Y.,
and Jan, Y. N.
(1995)
Neuron
14,
913-925[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Altman, J.,
and Bayer, S. A.
(1990)
J. Comp. Neurol.
301,
343-364[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Altman, J.,
and Bayer, S. A.
(1990)
J. Comp. Neurol.
301,
365-381[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Jensen, N. A.,
Smith, G. M.,
Garvey, J. S.,
Shine, H. D.,
and Hood, L.
(1993)
J. Neurosci. Res.
35,
288-296[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Jensen, N. A.,
Smith, G. M.,
Shine, H. D.,
Garvey, J. S.,
and Hood, L.
(1993)
J. Neurosci. Res.
34,
257-264[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Pedersen, K. M.,
Finsen, B.,
Celis, J. E.,
and Jensen, N. A.
(1999)
Electrophoresis
20,
249-255[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Li, J. Y.,
English, M. A.,
Ball, H. J.,
Yeyati, P. L.,
Waxman, S.,
and Licht, J. D.
(1997)
J. Biol. Chem.
272,
22447-22455[Abstract/Free Full Text]
|
| 12.
|
Olsen, J.,
Laustsen, L.,
Karnstrom, U.,
Sjostrom, H.,
and Noren, O.
(1991)
J. Biol. Chem.
266,
18089-18096[Abstract/Free Full Text]
|
| 13.
|
Jensen, N. A.,
West, M. J.,
and Celis, J. E.
(1999)
J. Biol. Chem.
274,
29921-29926[Abstract/Free Full Text]
|
| 14.
|
Kozak, M.
(1999)
Gene (Amst.)
234,
187-208[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Ye, B. H.,
Lista, F., Lo,
Coco, F.,
Knowles, D. M.,
Offit, K.,
Chaganti, R. S.,
and Dalla-Favera, R.
(1993)
Science
262,
747-750[Abstract/Free Full Text]
|
| 16.
|
Okabe, S.,
Fukuda, T.,
Ishibashi, K.,
Kojima, S.,
Okada, S.,
Hatano, M.,
Ebara, M.,
Saisho, H.,
and Tokuhisa, T.
(1998)
Mol. Cell. Biol.
18,
4235-4244[Abstract/Free Full Text]
|
| 17.
|
Chen, Z.,
Guidez, F.,
Rousselot, P.,
Agadir, A.,
Chen, S. J.,
Wang, Z. Y.,
Degos, L.,
Zelent, A.,
Waxman, S.,
and Chomienne, C.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
1178-1182[Abstract/Free Full Text]
|
| 18.
|
Peukert, K.,
Staller, P.,
Schneider, A.,
Carmichael, G.,
Hanel, F.,
and Eilers, M.
(1997)
EMBO J.
16,
5672-5686[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Bardwell, V. J.,
and Treisman, R.
(1994)
Genes Dev.
8,
1664-1677[Abstract/Free Full Text]
|
| 20.
|
Turner, J.,
and Crossley, M.
(1999)
Trends Biochem. Sci.
24,
236-241[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Grove, E. A.,
and Tole, S.
(1999)
Cereb. Cortex
9,
551-561[Abstract/Free Full Text]
|
| 22.
|
Tole, S.,
Christian, C.,
and Grove, E. A.
(1997)
Development
124,
4959-4970[Abstract]
|
| 23.
|
Pleasure, S. J.,
Collins, A. E.,
and Lowenstein, D. H.
(2000)
J. Neurosci.
20,
6095-6105[Abstract/Free Full Text]
|
| 24.
|
Rubenstein, J. L.,
and Rakic, P.
(1999)
Cereb. Cortex
9,
521-523[Free Full Text]
|
| 25.
|
Hatten, M. E.,
and Heintz, N.
(1995)
Annu. Rev. Neurosci.
18,
385-408[Medline]
[Order article via Infotrieve]
|
| 26.
|
Goldowitz, D.,
and Hamre, K.
(1998)
Trends Neurosci.
< |